Cargando…
Intestinal Inflammation Modulates the Epithelial Response to Butyrate in Patients With Inflammatory Bowel Disease
BACKGROUND: Butyrate-producing gut bacteria are reduced in patients with active inflammatory bowel disease (IBD), supporting the hypothesis that butyrate supplementation may be beneficial in this setting. Nonetheless, earlier studies suggest that the oxidation of butyrate in IBD patients is altered....
Autores principales: | Ferrer-Picón, Elena, Dotti, Isabella, Corraliza, Ana M, Mayorgas, Aida, Esteller, Miriam, Perales, José Carlos, Ricart, Elena, Masamunt, Maria C, Carrasco, Anna, Tristán, Eva, Esteve, Maria, Salas, Azucena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6905302/ https://www.ncbi.nlm.nih.gov/pubmed/31211831 http://dx.doi.org/10.1093/ibd/izz119 |
Ejemplares similares
-
Multi-omic modelling of inflammatory bowel disease with regularized canonical correlation analysis
por: Revilla, Lluís, et al.
Publicado: (2021) -
Generation of human colon organoids from healthy and inflammatory bowel disease mucosa
por: Dotti, Isabella, et al.
Publicado: (2022) -
A Novel Strategy to Study the Invasive Capability of Adherent-Invasive Escherichia coli by Using Human Primary Organoid-Derived Epithelial Monolayers
por: Mayorgas, Aida, et al.
Publicado: (2021) -
An RORγt Oral Inhibitor Modulates IL-17 Responses in Peripheral Blood and Intestinal Mucosa of Crohn's Disease Patients
por: Bassolas-Molina, Helena, et al.
Publicado: (2018) -
Dissecting Common and Unique Effects of Anti-α4β7 and Anti-Tumor Necrosis Factor Treatment in Ulcerative Colitis
por: Veny, Marisol, et al.
Publicado: (2020)